Search Results - "Antonio Olry Labry de Lima"

Refine Results
  1. 1
  2. 2

    A comparison of the accuracy of liquid cytology versus conventional screening: a meta-analysis of split-sample studies by Epstein, David, de Labry Lima, Antonio Olry, Mochón, Leticia García, Balbino, Jaime Espín, Esquivias, Javier

    “…The aim of the paper is to compare the accuracy and effectiveness of liquid-based versus conventional cytology when used as part of a process of population…”
    Get full text
    Journal Article
  3. 3

    A general framework for classifying costing methods for economic evaluation of health care by Špacírová, Zuzana, Epstein, David, García-Mochón, Leticia, Rovira, Joan, de Labry Lima, Antonio Olry, Espín, Jaime

    Published in The European journal of health economics (01-06-2020)
    “…According to the most traditional economic evaluation manuals, all "relevant" costs should be included in the economic analysis, taking into account factors…”
    Get full text
    Journal Article
  4. 4

    Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs by Espín, Jaime, Špacírová, Zuzana, Rovira, Joan, Epstein, David, Olry de Labry Lima, Antonio, García-Mochón, Leticia

    Published in BMC health services research (27-03-2022)
    “…Costs are one of the critical factors for the transferability of the results in health technology assessment and economic evaluation. The objective is to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Development and evaluation of an intervention based on the provision of patient feedback to improve patient safety in Spanish primary healthcare centres: study protocol by Serrano-Ripoll, Maria J, Ripoll, Joana, Llobera, Joan, Valderas, Jose Maria, Pastor-Moreno, Guadalupe, Olry de Labry Lima, Antonio, Ricci-Cabello, Ignacio

    Published in BMJ open (23-12-2019)
    “…IntroductionDespite the enormous potential for adverse events in primary healthcare (PHC), the knowledge about how to improve patient safety in this context is…”
    Get full text
    Journal Article
  7. 7

    HTA and decision-making processes in Central, Eastern and South Eastern Europe: Results from a survey by García-Mochón, Leticia, Espín Balbino, Jaime, Olry de Labry Lima, Antonio, Caro Martinez, Araceli, Martin Ruiz, Eva, Pérez Velasco, Román

    Published in Health policy (Amsterdam) (01-02-2019)
    “…Highlights • High level of heterogeneity in development of HTA structures, methods and processes.. • Differences related to politicized decision-making,…”
    Get full text
    Journal Article
  8. 8

    Description of day case costs and tariffs of cataract surgery from a sample of nine European countries by Olry de Labry Lima, Antonio, Špacírová, Zuzana, Espín, Jaime

    Published in Cost effectiveness and resource allocation (05-03-2022)
    “…The lack of transparency in the methodology of unit cost estimation and the usage of confidential or undisclosed information prevents cost comparisons and…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Optimal start in dialysis shows increased survival in patients with chronic kidney disease by Caro Martínez, Araceli, Olry de Labry Lima, Antonio, Muñoz Terol, José Manuel, Mendoza García, Óscar Javier, Remón Rodríguez, César, García Mochón, Leticia, Castro de la Nuez, Pablo, Aresté Fosalba, Nuria

    Published in PloS one (30-07-2019)
    “…To compare the survival among patients with chronic kidney disease who had optimal starts of renal replacement therapy, dialysis or hemodialysis, with patients…”
    Get full text
    Journal Article
  13. 13

    Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain by Olry de Labry Lima, Antonio, Díaz Castro, Óscar, Romero-Requena, Jorge M, García Díaz-Guerra, M de los Reyes, Arroyo Pineda, Virginia, de la Hija Díaz, M Belén, Ascanio, Meritxell, Darbà, Josep, Cruzado, Josep M

    Published in Clinical kidney journal (01-11-2021)
    “…Background Hyperkalaemia (HK) is a common electrolyte disorder in patients with chronic kidney disease (CKD) and/or treated with renin–angiotensin–aldosterone…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs by García, Miguel Angel Fernández, Olry de Labry Lima, Antonio, Ferrer Lopez, Ingrid, Bermúdez-Tamayo, Clara

    “…To analyse trends in the rates of consumption of benzodiazepine (BZD) anxiolytics, BZD hypnotics and non-BZD hypnotics and the association with contextual…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Challenges for Economic Evaluations of Advanced Therapy Medicinal Products: A Systematic Review by Olry de Labry-Lima, Antonio, Ponce-Polo, Angela, García-Mochón, Leticia, Ortega-Ortega, Marta, Pérez-Troncoso, Daniel, Epstein, David

    Published in Value in health (01-01-2023)
    “…Advanced therapy medicinal products (ATMPs) are drugs for human use for the treatment of chronic, degenerative, or life-threatening diseases that are based on…”
    Get full text
    Journal Article
  18. 18
  19. 19

    No differences in quality of life between men and women undergoing HIV antiretroviral treatment. Impact of demographic, clinical and psychosocial factors by Pérez, Isabel Ruiz, Olry de Labry Lima, Antonio, del Castillo, Luis Sordo, Baño, Jesús Rodríguez, Ruz, Miguel Ángel López, del Arco Jimenez, Alfonso

    Published in AIDS care (01-08-2009)
    “…Introduction. The health-related quality of life (HRQL) is therefore a highly important tool for the evaluation of the health status of HIV positive patients…”
    Get full text
    Journal Article
  20. 20